Dr. Arnold Demain is currently a Fellow at Drew University's Charles A. Dana Institute for Scientists Emeriti. Dr. Demain has been in the forefront of industrial microbiology and biotechnology for over four decades and has been involved in the research and commercialization of a number of fermentation-based pharmaceutical processes. Previously, he was at the Massachusetts Institute of Technology (MIT) for 32 years, where he most recently served as Professor of Industrial Microbiology in the Department of Biology. Before going to MIT, Dr. Demain spent fifteen years at Merck & Co., where he held various positions in R&D and management focused on fermentation microbiology. He received a Ph.D from the University of California, Berkeley and Davis.